Effective: December 16, 2020
Latest Legislation: House Bill 341 - 133rd General Assembly
(A) In accordance with divisions (B) and (C) of this section, a terminal distributor of dangerous drugs may acquire and maintain a supply of naloxone for use in emergency situations and for distribution through an automated mechanism. The naloxone may be maintained at a location other than the location licensed as a terminal distributor of dangerous drugs.
(B) In the case of naloxone for use in emergency situations, a terminal distributor of dangerous drugs shall do all of the following:
(1) Provide instructions regarding the emergency administration of naloxone to any individual who accesses the naloxone, including a specific instruction to summon emergency services as set forth in division (D) of this section;
(2) Specify a process to be used to notify the terminal distributor that the naloxone has been accessed within a reasonable time of its being accessed;
(3) Maintain the naloxone in accordance with the manufacturer's or distributor's instructions.
(C) In the case of naloxone for distribution through an automated mechanism, a terminal distributor of dangerous drugs shall comply with standards and procedures specified in rules adopted under division (F) of this section.
(D)(1) Notwithstanding any conflicting provision of the Revised Code, both of the following apply:
(a) Any individual may access naloxone maintained as provided in division (B) of this section and may administer it to an individual who there is reason to believe is experiencing an opioid-related overdose.
(b) Any individual may receive naloxone distributed through an automated system as provided in division (C) of this section and may administer it to an individual who there is reason to believe is experiencing an opioid-related overdose.
(2) An individual who administers naloxone as authorized by this section shall make a good faith effort to activate or have another individual activate an emergency medical services system as soon as possible, except that this requirement does not apply if the individual administering the naloxone is doing so as part of an emergency medical services system or at a hospital, as defined in section 3727.01 of the Revised Code.
(E) An individual is not liable for or subject to any of the following for injury, death, or loss to person or property that allegedly arises from an act or omission associated with any action authorized by this section, unless the act or omission constitutes willful or wanton misconduct: damages in any civil action, prosecution in any criminal proceeding, or professional disciplinary action.
(F) The state board of pharmacy shall adopt rules establishing standards and procedures applicable to the distribution of naloxone through an automated mechanism. The rules shall be adopted in accordance with Chapter 119. of the Revised Code.